期刊文献+

四种肝病相关自身抗体联合检测在肝功能异常血清中的临床价值

Analysis on the co-detection of autoantibodies in patients with abnormal liver function
下载PDF
导出
摘要 目的探讨4种肝病相关自身抗体在肝功能异常患者血清中的阳性率及其诊断价值。方法间接免疫荧光法检测血清中ANA、SMA、AMA、抗LKM-Ⅰ,根据荧光反应强弱判定结果。结果150例肝功异常患者(ALT>50U/L)自身抗体阳性率为18.7%(28/150),其中抗核抗体(ANA)、抗平滑肌抗体(SMA)及抗线粒体抗体(AMA)的阳性率分别为12.7%(19/150)、6.7%(10)/150)和7.3%(11/150);未检出抗肝肾微粒体Ⅰ型抗体(LKM-Ⅰ);女性患者自身抗体的检出率明显高于男性患者(P<0.05);病毒性肝炎标志物阴性组自身抗体检出率明显高于阳性组(P<0.05)。结论自身抗体对自身免疫性肝病在诊断疾病、了解病程和观察疗效中具有很重要的价值,肝功能异常的非病毒性肝炎病人适合进行肝病相关自身抗体的检测。 Objective To investigate the positive rates of four autoantibodies in patients with abnormal liver function and explore the clinical significance of the autoantibodies related to liver diseases. Methods 150 patients with abnormal liver function were detected for ANA, SMA, anti-LKM-I and AMA using indirect immunofluorescence. Results of 18% positive rates of autoantibodies, ANA, SMA, and SMA were 12.7%, 6.7% and 7.3%, and the level of female group was higher than that of male group (P〈0.05), non-viral hepatitis group was higher than those of viral hepatitis group (P〈0.05). Conclusions The detection of autoantibodies may be useful for the diagnosis of autoimmune liver diseases. The non-viral hepatitis patients with abnormal liver function are suitable for detecting hipatitis-associated autoantibodies.
出处 《实验与检验医学》 CAS 2008年第5期479-480,540,共3页 Experimental and Laboratory Medicine
关键词 自身免疫性肝炎 自身抗体 间接免疫荧光法 Autoimmune hepatitis Autoimmune antibodies Indirect immunofluorescence
  • 相关文献

参考文献9

  • 1[1]Joshi S,Cauch-Dudek K,Heathcote EJ,et al.Antimitochondrial antibody profiles:are they valid prognostic indicators in primary biliary cirrhosis[J]? Am J Gastroenterol,2002,97:999~1000.
  • 2朱刚剑,陈嵩,毛青,王宇明.原发性胆汁性肝硬化和自身免疫性肝炎重叠综合征的临床与病理分析[J].中华肝脏病杂志,2005,13(1):6-8. 被引量:11
  • 3[3]Feld JJ,Heathcote EJ.Epidemiolgy of autoimmune liver disease[J].J Gastroenterol Hepatol,2003,18:1118~1128.
  • 4[4]McFarlane IC.Lesson about antiboides in autoimmune hepatitis[J].Lancer,2000,355:1475~1476.
  • 5[5]Margaret F,David E.Antimitochondrial and other antibodies in primary biliary cirrhosis[M].2nd et.Amsterdam:Elseviver,1998,287~304.
  • 6闵福援,王健.自身免疫性肝炎[J].中华检验医学杂志,2004,27(9):623-624. 被引量:6
  • 7[8]Lacerda MA,Ludwig J,Dickson ER,et al.Antimitochondrial antibody-nesative primary biliary cirrhosis[J].Am J Gastrcenterol,1995,90:247~249.
  • 8[9]Czaja A J,Carpenter HA.Antoimmune hepatitis with inc-idental histologic features of bile duet injury[J].Hepatology,2001,34:659~665.
  • 9[10]Tanaka A,Miyakawa H,Luketic VA,et al.The diagnostic value of anti-mitochondrial antibodies,especially in primary biliary cirrhosis[J].Cell Mol Biol,2002,48:295~299,

二级参考文献4

  • 1Chuzouilleres O,Wendum D.serfaty L.et al.Primiry billary cirrhosis-autoimmune hepatitis overlap syndrome clinical features and response to therapy.Hepatology.1998.28:296-301.
  • 2Heathcote EJ.Management of primary biliary cirrhosis.The American association for the study of liver diseases practice guidelines.Hepatology,2000.31:1005-1013.
  • 3Alvarez F.Berg PA.Bianchi FB.et al.International Autoimmune Hepatitis Group Report:review of diagnosis of autoimmune bepatitis.J Hepatol.1999.31:929-938.
  • 4Czaja A.Carpenter HA.Validation of scoring system for diagnosis of autoimmunc hepatitis.Dig Dis Sci.1996.41:305-314.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部